OncoNext ™ Risk Breast is a diagnostic test, developed by GENOMA Group, which allows you to perform a multiple genetic analysis to assess the predisposition to the development of breast cancer.
The test, therefore, allows you to identify patients at risk of developing this neoplasia by analyzing their DNA.